{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:31:02Z","timestamp":1774881062598,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.chest.2022.10.003","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:09:15Z","timestamp":1675760955000},"page":"e53-e56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Marked Improvement in Soft Tissue and CNS Manifestations of Adult Langerhans Cell Histiocytosis on Targeted MEK Inhibitor Therapy"],"prefix":"10.1016","volume":"163","author":[{"given":"Hong T.","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Wikenheiser-Brokamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Udstuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blaise","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis X.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2022.10.003_bib1","author":"Tillotson"},{"issue":"6","key":"10.1016\/j.chest.2022.10.003_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12519-019-00304-9","article-title":"Childhood Langerhans cell histiocytosis: a disease with many faces","volume":"15","author":"Leung","year":"2019","journal-title":"World J Pediatr"},{"issue":"4","key":"10.1016\/j.chest.2022.10.003_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.survophthal.2012.09.004","article-title":"Langerhans Cell Histiocytosis of the orbit","volume":"58","author":"Herwig","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.chest.2022.10.003_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0003-2020","article-title":"Paediatric pulmonary Langerhans cell histiocytosis","volume":"16","author":"Barclay","year":"2020","journal-title":"Breathe"},{"issue":"3","key":"10.1016\/j.chest.2022.10.003_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89473","article-title":"Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes","volume":"2","author":"Lee","year":"2017","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.chest.2022.10.003_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28712","article-title":"Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib","volume":"67","author":"Messinger","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1016\/j.chest.2022.10.003_bib7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"Rodriguez-Galindo","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.chest.2022.10.003_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.chest.2022.10.003_bib9","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1111\/cas.13817","article-title":"Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment","volume":"109","author":"Kobayashi","year":"2018","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.chest.2022.10.003_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12185-011-0955-z","article-title":"Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis","volume":"94","author":"Imashuku","year":"2011","journal-title":"Int J Hematol"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222039241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222039241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:04:16Z","timestamp":1715130256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222039241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0012369222039241"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.10.003","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marked Improvement in Soft Tissue and CNS Manifestations of Adult Langerhans Cell Histiocytosis on Targeted MEK Inhibitor Therapy","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}